Raging Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Other funds holding INSY
WS
Raging Capital Management's INSY Position: Q2 2019 in Review
Raging Capital Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 295,790 shares — an estimated $1.37M sold.
Raging Capital Management first reported a position in INSY in Q1 2016 and held it in 5 quarters. The position peaked at $1.37M in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Raging Capital Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Raging Capital Management sold 295,790 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1.37M.
- Raging Capital Management first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 5 quarters.
- Raging Capital Management's Insys Therapeutics, Inc. position peaked at $1.37M in Q1 2019.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Raging Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.